Download Docs
Export

HEMO+

79286967 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Dec. 20, 2019
Serial No. 79286967
Examining Attorney KIMBERLY MORGAN RAY
Class Concentrated pharmaceutical products for hemodialysis treatment, packaged in drums and containers, and diluted products for hemodialysis treatment; pharmaceutical products for hemodialysis and other treatments packaged in flexible bags or glass ampoules, especially solid solutes such as glucose for rehydration and calorie intake; glycocol as a solution for irrigation of blood; mannitol as a solution for irrigation of blood; pharmaceutical preparation, namely, glucose/NaCl mix, for rehydration; pharmaceutical preparation, namely, Ringer's lactate solution for hydroelectric rebalance, hypovolemia, maintaining acid-base balance; pharmaceutical preparation, namely, sodium chloride for rehydration and hydroelectric rebalance, water for injection (WFI) for injectable preparations in the nature of irrigation solution for irrigation of blood; pharmaceutical preparation, namely, generic medical preparations, in the nature of ciprofloxacin as an antibiotic; pharmaceutical preparation, namely, fluconazole as an antifungal, ketoprofen as an analgesic and anti-inflammatory; pharmaceutical preparation, namely, levobupivacaine as an anesthetic; pharmaceutical preparation, namely, levofloxacin as an antibiotic; pharmaceutical preparation, namely, metronidazole as an antibiotic and antiparasitic; pharmaceutical preparation, namely, morphine hydrochloride as an analgesic; pharmaceutical preparation, namely, moxifloxacin as an antibiotic; pharmaceutical preparation, namely, ofloxacin as an antibiotic; pharmaceutical preparation, namely, paracetamol as an analgesic and antipyretic, ropivacaine Hcl as an anaesthetic; pharmaceutical preparation, namely, tirofiban as an anticoagulant; pharmaceutical preparation, namely, zoledronic acid for patients suffering from osteoporosis; pharmaceutical preparation, namely, injectable ampoules containing medicated preparations, namely, quinine as an antimalarial, potassium chloride for hypokalemia, hydroelectric rebalancing; pharmaceutical preparation, namely, sodium chloride for hydroelectric rebalancing; pharmaceutical preparation, namely, water for injection (WFI) as a vehicle for parenteral administration; pharmaceutical preparation, namely, magnesium sulfate for hypokalemia, eclampsia, torsade de pointe, hypocalcemia; pharmaceutical preparation, namely, sodium bicarbonate for metabolic acidosis, cardiovascular arrest; pharmaceutical preparation, namely, glucose for carbohydrate calorie intake; 005; 006; 018; 044; 046; 051; 052; 002; 012; 013; 014; 023; 025; 050; 021; 023; 026; 036; 038; 026; 039; 044; 013; 021; 023; 024; 031; 034; 100; 103; 106; 100; 101; 107; 100; 101
HEMO+
Status Application has been published for opposition. The opposition period begins on the date of publication.
Last Updated: 3 years, 5 months ago
Filing Date # Docket Text